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Major Coronary Artery
Anomalies in the Pediatric Population
We read with interest the article by Davis et al. (1). The
investigators nicely address the problems related to the identifica-
tion and treatment of these rare coronary anomalies. Although
agreeing with the indications for intervention, we believe that
aortocoronary bypass grafting may not be the optimal treatment.
The long-term patency of arterial grafts (78% at 10 years for
internal thoracic artery grafts in the treatment of young patients
after Kawasaki disease) (2) may not be satisfactory for children. In
addition, given that most of the time the flow through the affected
coronary is unimpeded, the graft sets up a competitive flow, which
might jeopardize long-term patency. We have taken a different
approach, adapted from the translocation of intramural coronary
arteries during the arterial switch operation for transposition of the
great arteries. The inner wall of the sinus of Valsalva along the
intramural portion of the artery is excised to enlarge the ostium.
An autologous pericardial patch is used to enlarge the proximal
portion of the artery on its external aspect. This is readily
accomplished by transection of the aorta and pulmonary artery to
obtain a good exposure. This strategy eliminates the acute takeoff
angle and external compression of the anomalous coronary, while
avoiding competitive flow through a graft, and thus may result in
better long-term patency than aortocoronary bypass. We offer this
as an alternative to the use of aortocoronary bypass or internal
thoracic artery grafting.
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REPLY
The letters from Drs. Davidson and Karl and Dr. Phoon highlight
the controversy and difficulties inherent in planning intervention
for anomalous origin of the coronary arteries (AOCA). The
principal goal of our study was to estimate the prevalence of these
anomalies in a relatively normal and asymptomatic population (1).
This represents only the first step in defining a disease process.
Phoon correctly states that the true natural history of these
coronary artery anomalies is unknown. The sporadic nature of
AOCA causes difficulties in determining the natural history of
these abnormalities when they present as an incidental finding.
Conceivably, a national or international registry for such patients
could be established with the goal of defining both the natural and
surgical history of these patients.
We concur with the management outline described in the
editorial comment by Pellicia (2). Certainly, surgical intervention
is mandatory in any young patient with symptoms; or those with
AOCA as an incidental finding and signs of myocardial perfusion
abnormalities identified after rigorous laboratory examination.
Pellicia states that uncertainty exists regarding patients without
symptoms or signs of myocardial ischemia. Therefore, it seems
reasonable that these patients are not exposed to risk for sudden
death, and surgical management should be considered. One can
take issue with Phoon’s statement that “activity can be modified,
and therefore risk can be reduced.” Behavioral modification might
be possible, but at what price? Our patients and their families are
routinely provided the option of reduced physical activity as an
alternative to operative intervention. In this population of other-
wise healthy young persons, lifestyle considerations tend to direct
the families to choose surgical treatment.
The surgical approach depends on the specific anatomy and
circumstances. Davidson and Karl suggest that aortocoronary
bypass grafting may not be the optimal procedure for AOCA. We
agree that arterioplasty involving the ostium is appropriate and
perhaps preferable, when the right coronary artery with anomalous
origin (ARCA) follows an intramural course. We have performed
this operation in two patients with good immediate results. In two
other patients, the ARCA did not demonstrate an intramural
course, and bypass seemed preferable. We have operated on three
patients with left coronary arteries arising from the right sinus, all
without intramural component and all were bypassed. All of these
grafts have remained patent up to three years postoperatively.
Furthermore, two of the three grafts were performed without
cardiopulmonary bypass, thus avoiding possible neurological com-
plications. The long-term results including graft patency duration
for these surgical procedures remain unknown. Extrapolation of
data regarding Kawasaki disease patients to AOCA patients may
not be appropriate (3). Kawasaki disease is a vasculitic syndrome
associated with increased risk for thrombosis (4). Vascular remod-
eling can continue for years (5) and possibly promote graft occlusion.
Such vascular pathology does not exist in AOCA patients.
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